设为首页收藏本站
开启辅助访问 切换到窄版

 找回密码
 To register

QQ登录

只需一步，快速开始

扫一扫，访问微社区

  • ALL
  • Journals
  • Books

派博传思国际中心 »期刊书目

› Journal of SCIE
› PHARMACOLOGY & PHARMACY(药理学与药学)

1234下一页
返回列表

SCIE期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY 2024/2025影响因子:2.771 (CANCER CHEMOTH PHARM) (0344-5704). (PHARMACOLOGY & PHAR

[复制链接]
查看: 49890|回复: 35
发表于 2025-3-21 16:16:59 | 显示全部楼层 |阅读模式
期刊全称CANCER CHEMOTHERAPY AND PHARMACOLOGY
期刊简称CANCER CHEMOTH PHARM
影响因子20242.771
视频video
ISSN0344-5704
eISSN1432-0843
出版商SPRINGER
发行地址ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United States, NY, 10004
学科分类1.Science Citation Index Expanded (SCIE)--Oncology | Pharmacology & Pharmacy; 2.Biological Abstracts--Oncology | Pharmacology & Pharmacy; 3.BIOSIS Previews_BIOSIS Citation Index--Oncology | Pharmacology & Pharmacy; 4.Current Contents Clinical Medicine--Oncology; 5.Current Contents Life Sciences--Oncogenesis & Cancer Research; 6.Essential Science Indicators--Clinical Medicine;
出版语言English
The information of publication is updating

SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(20 21 REV HIST)影响因子


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(CANCER CHEMOTH PHARM)影响因子@(药理学与药学)学科排名


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(20 21 REV HIST)总引论文


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(CANCER CHEMOTH PHARM)总引论文@(药理学与药学)学科排名


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(20 21 REV HIST)影响因子


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(CANCER CHEMOTH PHARM)总引频次@(药理学与药学)学科排名


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(20 21 REV HIST)即时影响因子


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(CANCER CHEMOTH PHARM)即时影响因子@(药理学与药学)学科排名


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(20 21 REV HIST)五年累积影响因子


SCIE(SCI)期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY(CANCER CHEMOTH PHARM)五年累积影响因子@(药理学与药学)学科排名


单选投票, 共有 1 人参与投票
1.jpg
 

0票 0.00%

Perfect with Aesthetics
2.jpg
 

0票 0.00%

Better Implies Difficulty
3.jpg
 

1票 100.00%

Good and Satisfactory
4.jpg
 

0票 0.00%

Adverse Performance
5.jpg
 

0票 0.00%

Disdainful Garbage
您所在的用户组没有投票权限
Baleful
回复

举报

发表于 2025-3-22 00:04:38 | 显示全部楼层
endarterectomy
回复

举报

发表于 2025-3-22 03:05:31 | 显示全部楼层
Submitted on: 28 March 2011. Revised on: 02 May 2011. Accepted on: 28 June 2011. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY
CLAIM
回复

举报

发表于 2025-3-22 08:13:33 | 显示全部楼层
Submitted on: 30 March 2001. Revised on: 08 July 2001. Accepted on: 07 August 2001. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY
吞下
回复

举报

发表于 2025-3-22 10:38:39 | 显示全部楼层
繁重
回复

举报

发表于 2025-3-22 14:10:41 | 显示全部楼层
Submitted on: 27 April 2005. Revised on: 05 July 2005. Accepted on: 02 September 2005. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY
清楚说话
回复

举报

发表于 2025-3-22 20:21:48 | 显示全部楼层
Submitted on: 01 September 2021. Revised on: 14 October 2021. Accepted on: 30 October 2021. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY
小样他闲聊
回复

举报

发表于 2025-3-23 00:47:37 | 显示全部楼层
赞成你
回复

举报

发表于 2025-3-23 02:53:31 | 显示全部楼层
jumble
回复

举报

发表于 2025-3-23 09:13:24 | 显示全部楼层
名字
回复

举报

下一页 »
1234下一页
返回列表
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 09:41
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表